CEA Targeting CAR-T (PTC13)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEA Targeting CAR-T (PTC13), covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors [Phase 1]